Steroid Receptor Co-Activators Regulate Metabolic Kinases to Drive Therapy Resistant ER+ Breast Cancer

Recurrence of metastatic breast cancer stemming from acquired endocrine and chemotherapy resistance remains a health burden for women with luminal (ER+) breast cancer. Disseminated ER+ tumor cells can remain viable but quiescent for years to decades. Contributing factors to metastatic spread include...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Endocr Soc
Autores principales: Truong, Thu Ha, Benner, Elizabeth A, Hagen, Kyla M, Temiz, Nuri A, Kerkvliet, Carlos Perez, Wang, Ying, Cortes-Sanchez, Emilio, Yang, Chieh-Hsiang, Pengo, Thomas, Guillen, Katrin P, Welm, Bryan E, Telang, Sucheta, Lange, Carol A, Ostrander, Julie Hanson
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2021
Materias:
Tumor Biology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8089334/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.2111
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares